| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $195.0M | +33.7% |
| R&D Expense | $17.9M | +64.0% |
| SG&A Expense | $75.3M | +145.9% |
| Operating Income | $13.0M | +840.1% |
| Pre-tax Income | -$7K | -100.1% |
| Income Tax | -$859K | — |
| Net Income | $852K | -96.3% |
| EPS (Basic) | $0.01 | -66.7% |
| EPS (Diluted) | $0.01 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $8.7M | -44.7% |
| Accounts Receivable | $22.4M | +25.4% |
| Current Assets | $43.2M | — |
| Total Assets | $438.8M | +54.2% |
| Current Liabilities | $61.9M | — |
| Long-term Debt | $360.6M | +163.0% |
| Total Liabilities | $434.8M | +1092.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $50.6M | +4701.9% |
| Capital Expenditures | $430K | +59.9% |
| Investing Cash Flow | -$5.6M | -1.2% |
| Financing Cash Flow | -$52.1M | -1048.7% |
| Free Cash Flow | $50.2M | +3766.6% |
| -66.7% |
| Stockholders' Equity |
| $4.1M |
| +111.2% |